APAC China - How pharma can maximise success

Complete the form below to view the webcast.

China has always been believed to be the land of promise for multinational pharmaceutical companies. The country’s recent 2020 healthcare reforms aim to rapidly increase the pace of new drug approvals and fast track innovative treatments, for the pharmaceutical industry.

China - How pharma can maximise success in this rapidly changing emerging market

Complete the form below to view the webcast.

The recent digital transformation as a result of the COVID-19 pandemic has also led China to adopt new approaches to healthcare. Market researchers need to keep up to speed with the changes in order to win in this rapidly changing market. The webcast is presented by Pei Li Teh and Wan Ling Neo who are based in our Singapore office.

Topics covered in this webcast include:

What's planned? An overview of the healthcare environment in China including an assessment of what recent developments mean to you
What's changed? The key opportunities, including digital transformations and healthcare reforms
Where to play & how to win: Case studies showcasing how to design an effective marketing strategy, with Oncology and Vaccine examples amongst others

Research Partnership is delighted to offer free attendance to this webinar. However, in order to attend, you will need to register with your company email address.

Webcast: China - How pharma can maximise success in this rapidly changing emerging market

Watch the webcast

Sign up to receive Rapport

Webcast: China - How pharma can maximise success in this rapidly changing emerging market

Form Header

Form Header

Watch the webcast

Sign up to receive Rapport